![Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern | Clinical Epigenetics | Full Text Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern | Clinical Epigenetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13148-020-00843-3/MediaObjects/13148_2020_843_Figa_HTML.png)
Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern | Clinical Epigenetics | Full Text
![Cohort selection. Abbreviations: ADA, adalimumab; CD, Crohn's disease;... | Download Scientific Diagram Cohort selection. Abbreviations: ADA, adalimumab; CD, Crohn's disease;... | Download Scientific Diagram](https://www.researchgate.net/publication/322935593/figure/fig1/AS:590670276349952@1517838176432/Cohort-selection-Abbreviations-ADA-adalimumab-CD-Crohns-disease-IBD-inflammatory.png)
Cohort selection. Abbreviations: ADA, adalimumab; CD, Crohn's disease;... | Download Scientific Diagram
![Crohn's Disease (CD) | Padmavathi Gastro and Liver Hospital in Miyapur, near madinaguda | Best liver transplant hospital in Hyderabad Crohn's Disease (CD) | Padmavathi Gastro and Liver Hospital in Miyapur, near madinaguda | Best liver transplant hospital in Hyderabad](http://padmavathigastro.com/assets/images/services/crown-des.jpg)
Crohn's Disease (CD) | Padmavathi Gastro and Liver Hospital in Miyapur, near madinaguda | Best liver transplant hospital in Hyderabad
![Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/b1cdd688-9db2-471c-a4a1-371fe7e7be5b/gr1_lrg.jpg)
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology
![Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study - ScienceDirect Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356521009113-fx1.jpg)